查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513335

痤瘡治療藥物市場：按治療層級、按配方、按類型、按痤瘡類型、按分銷管道：2024-2035 年全球機會分析和行業預測

Acne Medication Market By Therapeutic Class, By Formulation, By Type, By Acne Type, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2024-2035
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
2023年全球痤瘡治療藥物市場價值為134億美元，預計2024年至2035年複合年成長率為5.1%，到2035年達到242億美元。痤瘡是一種常見的皮膚病，其特徵是形成丘疹、黑頭、白斑、囊腫和結節，通常出現在臉部、胸部、背部和肩部。當毛囊被皮脂和死皮細胞堵塞，導致細菌生長和發炎時，就會出現痤瘡。痤瘡的形成涉及多種因素，包括荷爾蒙波動、遺傳、皮脂分泌過多、細菌以及某些藥物和化妝品。治療方法包括類視色素A、抗生素、水楊酸、過氧化苯甲醯和其他藥物。
痤瘡藥物市場-IMG1
由於痤瘡發病率上升和不健康飲食，預計痤瘡藥物市場將顯著成長。痤瘡是全世界最常見的皮膚病之一，影響所有年齡、性別和種族的人。由於荷爾蒙變化、環境影響、飲食習慣和生活方式選擇等因素，其盛行率多年來穩步上升。根據國家醫學圖書館 2023 年發表的一篇論文，尋常性痤瘡在青少年和年輕人中很常見。據估計，青少年尋常性痤瘡的盛行率為 35% 至 90% 以上。此外，不健康的生活方式是痤瘡治療藥物市場的關鍵促進因素。不良飲食、高壓力、睡眠不足和接觸環境污染物等生活方式因素會導致痤瘡的發生和惡化。富含精製糖、加工食品和乳製品的不均衡飲食會導致荷爾蒙波動並增加皮脂分泌。此外，壓力水平的增加會刺激皮質醇等壓力荷爾蒙的分泌，引起發炎並使現有的痤瘡病變惡化。根據美國焦慮與憂鬱症協會 2023 年的一篇報導，整體焦慮症影響著 680 萬成年人，即美國人口的 3.1%。此外，睡眠不足會破壞身體的自然癒合過程並削弱免疫系統，使您更容易受到細菌感染和與痤瘡相關的發炎。因此，不健康的生活方式導致痤瘡發病率增加以及對痤瘡治療藥物的需求增加。痤瘡治療市場按治療層級、配方、類型、痤瘡類型、分銷管道和地區進行細分。依治療層級，市場分為類視色素A、抗生素、水楊酸、過氧化苯甲醯等。依劑型分類，市場分為外用藥物和內服藥物。按類型分類，市場分為處方藥和非處方藥。依痤瘡類型，市場分為非發炎痤瘡和發炎痤瘡。依分銷管道分為零售店、藥局/藥局和電子商務。按地區分類，北美（美國、加拿大、墨西哥）、歐洲（德國、法國、英國、義大利、西班牙、其他歐洲國家地區）、亞太地區（日本、中國、澳洲、印度、韓國、其他亞洲地區） -太平洋地區），在亞太地區（巴西、沙烏地阿拉伯、非洲和其他歐洲國家）進行分析。痤瘡治療藥物市場的主要主要企業有 Bausch Health Companies Inc、Mayne Pharma Group Limited、Sun Pharmaceutical Industries Limited、Johnson and Johnson、GlaxoSmithKline Plc、Mylan NV、Almirall Sa、Galderma SA、Teva Pharmaceutical Industries Ltd.、Pfizer Inc 。主要企業正在採用收購作為關鍵發展策略，以改善產品系列。

相關人員的主要利益

  • 該報告定量分析了 2023 年至 2035 年痤瘡藥物市場分析的細分市場、當前趨勢、估計/趨勢和動態，並確定了痤瘡藥物市場的強大機會。
  • 我們提供市場研究以及與市場促進因素、市場限制和市場機會相關的資訊。
  • 波特的五力分析強調買家和供應商幫助相關人員做出利潤驅動的商業決策並加強供應商-買家網路的力量。
  • 對痤瘡治療藥物市場細分的詳細分析有助於識別市場機會。
  • 每個地區的主要國家都根據其對全球市場的收益貢獻繪製了地圖。
  • 市場參與者定位有助於基準化分析，並提供對市場參與者當前位置的清晰了解。
  • 該報告包括對區域和全球痤瘡治療藥物市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章：痤瘡治療藥物市場：依治療層級

  • 概述
  • 類視色素A
    • 按類型分類的類類視色素A痤瘡藥物市場
  • 抗生素
    • 按類型分類的抗生素痤瘡治療市場
  • 水楊酸
  • 過氧化苯甲醯
  • 其他藥品

第5章痤瘡治療藥物市場：按配方

  • 概述
  • 外用製劑
  • 口腔醫學

第6章痤瘡治療藥物市場：按類型

  • 概述
  • 處方藥
  • 非處方藥物

第7章痤瘡治療藥物市場：按痤瘡類型

  • 概述
  • 非發炎痤瘡
  • 發炎痤瘡

第8章痤瘡治療藥物市場：按分銷管道

  • 概述
  • 零售店
  • 藥局/藥局
  • 電子商務

第9章痤瘡治療藥物市場：按地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 澳洲
    • 印度
    • 韓國
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第10章競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2023年主要企業定位

第11章 公司簡介

  • AbbVie Inc.
  • Botanix Pharmaceuticals
  • Galderma SA
  • Bausch Health Companies Inc
  • GlaxoSmithKline Plc.
  • Bayer AG
  • Kenvue Inc
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mayne Pharma Group Limited.
Product Code: A04007
The global acne medication market was valued at $13.4 billion in 2023, and is estimated to reach $24.2 billion by 2035, growing at a CAGR of 5.1% from 2024 to 2035. Acne is a common skin condition characterized by the formulation of pimples, blackheads, whiteheads, cysts, or nodules, usually appearing on the face, chest, back, or shoulders. It occurs when hair follicles become clogged with oil and dead skin cells, leading to the proliferation of bacteria and inflammation. Several factors contribute to the development of acne, including hormonal fluctuations, genetics, excess oil production, bacteria, and certain medications or cosmetics. The treatment includes retinoid, antibiotic, salicylic acid, benzoyl peroxide, and other medications.
Acne Medication Market - IMG1
The acne medication market is expected to register significant growth due to rise in incidences of acne and unhealthy diet. Acne is one of the most common skin conditions globally, affecting individuals of all ages, genders, and ethnicities. Its prevalence has been steadily increasing over the years, driven by factors such as hormonal changes, environmental influences, dietary habits, and lifestyle choices. According to a 2023 article by the National Library of Medicine, acne vulgaris is commonly observed in adolescents and young adults. Prevalence rate of acne vulgaris is estimated to range from 35% to over 90% among adolescents. Thus, rise in the prevalence of acne is expected to drive the growth of the market.Furthermore, an unhealthy lifestyle serves as a significant driver for the acne medication market. Lifestyle factors such as poor dietary habits, high stress levels, inadequate sleep, and exposure to environmental pollutants contribute to the development and exacerbation of acne. Unbalanced diets high in refined sugars, processed foods, and dairy products can trigger hormonal fluctuations and increase sebum production, both of which are key factors in acne formulation. In addition, elevated stress levels stimulate the release of stress hormones like cortisol, which can lead to inflammation and exacerbate existing acne lesions. According to a 2023 article by Anxiety and Depression Association of America, it was reported that Generalized Anxiety Disorder affects 6.8 million adults or 3.1% of the U.S. population. Furthermore, insufficient sleep disrupts the body's natural healing processes and weakens the immune system, making individuals more susceptible to bacterial infections and inflammation associated with acne. Thus, the unhealthy lifestyle has resulted in growing incidence of acne resulting in increase in demand for acne medication.The acne medication market is segmented on the basis of therapeutic class, formulation, type, acne type, distribution channel, and region. By therapeutic class, the market is divided into retinoid, antibiotic, salicylic acid, benzoyl peroxide, and others. By formulation, the market is classified into topical and oral medication. By type, the market is distributed into prescription medicine and over-the-counter medicines. By acne type, the market is distributed into non-inflammatory acne and inflammatory acne. By distribution channel, the market is classified into retail stores, pharmacy and drug stores, and e-commerce. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA)Major key players operating in the acne medication market are Bausch Health Companies Inc., Mayne Pharma Group Limited, Sun Pharmaceutical Industries Limited, Johnson and Johnson, GlaxoSmithKline Plc, Mylan N.V., Almirall Sa, Galderma S.A., Teva Pharmaceutical Industries Ltd., and Pfizer Inc. Key players have adopted acquisition as a key developmental strategy to improve the product portfolio of the acne medication market

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the acne medication market analysis from 2023 to 2035 to identify the prevailing acne medication market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the acne medication market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global acne medication market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Prescription Medicine
  • Over-the-counter medicines

By Therapeutic Class

  • Other medications
  • Retinoid
    • Type
    • Topical and Combination retinoid
    • Oral Retinoid
  • Antibiotic
    • Type
    • Topical and Combination Antibiotics
    • Oral Antibiotics
  • Salicylic Acid
  • Benzoyl Peroxide

By Acne Type

  • Non-inflammatory acne
  • Inflammatory acne

By Formulation

  • Topical Medication
  • Oral Medication

By Distribution Channel

  • Retail Store
  • Pharmacy and Drug Store
  • E-Commerce

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • AbbVie Inc.
    • Botanix Pharmaceuticals
    • Galderma S.A.
    • Bausch Health Companies Inc
    • GlaxoSmithKline Plc.
    • Bayer AG
    • Kenvue Inc
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mayne Pharma Group Limited.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Retinoid
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Retinoid Acne Medication Market by Type
  • 4.3. Antibiotic
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
    • 4.3.4. Antibiotic Acne Medication Market by Type
  • 4.4. Salicylic Acid
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Benzoyl Peroxide
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Other medications
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country

CHAPTER 5: ACNE MEDICATION MARKET, BY FORMULATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Topical Medication
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Oral Medication
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: ACNE MEDICATION MARKET, BY TYPE

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Prescription Medicine
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Over-the-counter medicines
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: ACNE MEDICATION MARKET, BY ACNE TYPE

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Non-inflammatory acne
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Inflammatory acne
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country

CHAPTER 8: ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

  • 8.1. Overview
    • 8.1.1. Market size and forecast
  • 8.2. Retail Store
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by region
    • 8.2.3. Market share analysis by country
  • 8.3. Pharmacy and Drug Store
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by region
    • 8.3.3. Market share analysis by country
  • 8.4. E-Commerce
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by region
    • 8.4.3. Market share analysis by country

CHAPTER 9: ACNE MEDICATION MARKET, BY REGION

  • 9.1. Overview
    • 9.1.1. Market size and forecast By Region
  • 9.2. North America
    • 9.2.1. Key market trends, growth factors and opportunities
    • 9.2.2. Market size and forecast, by Therapeutic Class
    • 9.2.3. Market size and forecast, by Formulation
    • 9.2.4. Market size and forecast, by Type
    • 9.2.5. Market size and forecast, by Acne Type
    • 9.2.6. Market size and forecast, by Distribution Channel
    • 9.2.7. Market size and forecast, by country
      • 9.2.7.1. U.S.
      • 9.2.7.1.1. Market size and forecast, by Therapeutic Class
      • 9.2.7.1.2. Market size and forecast, by Formulation
      • 9.2.7.1.3. Market size and forecast, by Type
      • 9.2.7.1.4. Market size and forecast, by Acne Type
      • 9.2.7.1.5. Market size and forecast, by Distribution Channel
      • 9.2.7.2. Canada
      • 9.2.7.2.1. Market size and forecast, by Therapeutic Class
      • 9.2.7.2.2. Market size and forecast, by Formulation
      • 9.2.7.2.3. Market size and forecast, by Type
      • 9.2.7.2.4. Market size and forecast, by Acne Type
      • 9.2.7.2.5. Market size and forecast, by Distribution Channel
      • 9.2.7.3. Mexico
      • 9.2.7.3.1. Market size and forecast, by Therapeutic Class
      • 9.2.7.3.2. Market size and forecast, by Formulation
      • 9.2.7.3.3. Market size and forecast, by Type
      • 9.2.7.3.4. Market size and forecast, by Acne Type
      • 9.2.7.3.5. Market size and forecast, by Distribution Channel
  • 9.3. Europe
    • 9.3.1. Key market trends, growth factors and opportunities
    • 9.3.2. Market size and forecast, by Therapeutic Class
    • 9.3.3. Market size and forecast, by Formulation
    • 9.3.4. Market size and forecast, by Type
    • 9.3.5. Market size and forecast, by Acne Type
    • 9.3.6. Market size and forecast, by Distribution Channel
    • 9.3.7. Market size and forecast, by country
      • 9.3.7.1. Germany
      • 9.3.7.1.1. Market size and forecast, by Therapeutic Class
      • 9.3.7.1.2. Market size and forecast, by Formulation
      • 9.3.7.1.3. Market size and forecast, by Type
      • 9.3.7.1.4. Market size and forecast, by Acne Type
      • 9.3.7.1.5. Market size and forecast, by Distribution Channel
      • 9.3.7.2. France
      • 9.3.7.2.1. Market size and forecast, by Therapeutic Class
      • 9.3.7.2.2. Market size and forecast, by Formulation
      • 9.3.7.2.3. Market size and forecast, by Type
      • 9.3.7.2.4. Market size and forecast, by Acne Type
      • 9.3.7.2.5. Market size and forecast, by Distribution Channel
      • 9.3.7.3. UK
      • 9.3.7.3.1. Market size and forecast, by Therapeutic Class
      • 9.3.7.3.2. Market size and forecast, by Formulation
      • 9.3.7.3.3. Market size and forecast, by Type
      • 9.3.7.3.4. Market size and forecast, by Acne Type
      • 9.3.7.3.5. Market size and forecast, by Distribution Channel
      • 9.3.7.4. Italy
      • 9.3.7.4.1. Market size and forecast, by Therapeutic Class
      • 9.3.7.4.2. Market size and forecast, by Formulation
      • 9.3.7.4.3. Market size and forecast, by Type
      • 9.3.7.4.4. Market size and forecast, by Acne Type
      • 9.3.7.4.5. Market size and forecast, by Distribution Channel
      • 9.3.7.5. Spain
      • 9.3.7.5.1. Market size and forecast, by Therapeutic Class
      • 9.3.7.5.2. Market size and forecast, by Formulation
      • 9.3.7.5.3. Market size and forecast, by Type
      • 9.3.7.5.4. Market size and forecast, by Acne Type
      • 9.3.7.5.5. Market size and forecast, by Distribution Channel
      • 9.3.7.6. Rest of Europe
      • 9.3.7.6.1. Market size and forecast, by Therapeutic Class
      • 9.3.7.6.2. Market size and forecast, by Formulation
      • 9.3.7.6.3. Market size and forecast, by Type
      • 9.3.7.6.4. Market size and forecast, by Acne Type
      • 9.3.7.6.5. Market size and forecast, by Distribution Channel
  • 9.4. Asia-Pacific
    • 9.4.1. Key market trends, growth factors and opportunities
    • 9.4.2. Market size and forecast, by Therapeutic Class
    • 9.4.3. Market size and forecast, by Formulation
    • 9.4.4. Market size and forecast, by Type
    • 9.4.5. Market size and forecast, by Acne Type
    • 9.4.6. Market size and forecast, by Distribution Channel
    • 9.4.7. Market size and forecast, by country
      • 9.4.7.1. Japan
      • 9.4.7.1.1. Market size and forecast, by Therapeutic Class
      • 9.4.7.1.2. Market size and forecast, by Formulation
      • 9.4.7.1.3. Market size and forecast, by Type
      • 9.4.7.1.4. Market size and forecast, by Acne Type
      • 9.4.7.1.5. Market size and forecast, by Distribution Channel
      • 9.4.7.2. China
      • 9.4.7.2.1. Market size and forecast, by Therapeutic Class
      • 9.4.7.2.2. Market size and forecast, by Formulation
      • 9.4.7.2.3. Market size and forecast, by Type
      • 9.4.7.2.4. Market size and forecast, by Acne Type
      • 9.4.7.2.5. Market size and forecast, by Distribution Channel
      • 9.4.7.3. Australia
      • 9.4.7.3.1. Market size and forecast, by Therapeutic Class
      • 9.4.7.3.2. Market size and forecast, by Formulation
      • 9.4.7.3.3. Market size and forecast, by Type
      • 9.4.7.3.4. Market size and forecast, by Acne Type
      • 9.4.7.3.5. Market size and forecast, by Distribution Channel
      • 9.4.7.4. India
      • 9.4.7.4.1. Market size and forecast, by Therapeutic Class
      • 9.4.7.4.2. Market size and forecast, by Formulation
      • 9.4.7.4.3. Market size and forecast, by Type
      • 9.4.7.4.4. Market size and forecast, by Acne Type
      • 9.4.7.4.5. Market size and forecast, by Distribution Channel
      • 9.4.7.5. South Korea
      • 9.4.7.5.1. Market size and forecast, by Therapeutic Class
      • 9.4.7.5.2. Market size and forecast, by Formulation
      • 9.4.7.5.3. Market size and forecast, by Type
      • 9.4.7.5.4. Market size and forecast, by Acne Type
      • 9.4.7.5.5. Market size and forecast, by Distribution Channel
      • 9.4.7.6. Rest of Asia-Pacific
      • 9.4.7.6.1. Market size and forecast, by Therapeutic Class
      • 9.4.7.6.2. Market size and forecast, by Formulation
      • 9.4.7.6.3. Market size and forecast, by Type
      • 9.4.7.6.4. Market size and forecast, by Acne Type
      • 9.4.7.6.5. Market size and forecast, by Distribution Channel
  • 9.5. LAMEA
    • 9.5.1. Key market trends, growth factors and opportunities
    • 9.5.2. Market size and forecast, by Therapeutic Class
    • 9.5.3. Market size and forecast, by Formulation
    • 9.5.4. Market size and forecast, by Type
    • 9.5.5. Market size and forecast, by Acne Type
    • 9.5.6. Market size and forecast, by Distribution Channel
    • 9.5.7. Market size and forecast, by country
      • 9.5.7.1. Brazil
      • 9.5.7.1.1. Market size and forecast, by Therapeutic Class
      • 9.5.7.1.2. Market size and forecast, by Formulation
      • 9.5.7.1.3. Market size and forecast, by Type
      • 9.5.7.1.4. Market size and forecast, by Acne Type
      • 9.5.7.1.5. Market size and forecast, by Distribution Channel
      • 9.5.7.2. Saudi Arabia
      • 9.5.7.2.1. Market size and forecast, by Therapeutic Class
      • 9.5.7.2.2. Market size and forecast, by Formulation
      • 9.5.7.2.3. Market size and forecast, by Type
      • 9.5.7.2.4. Market size and forecast, by Acne Type
      • 9.5.7.2.5. Market size and forecast, by Distribution Channel
      • 9.5.7.3. South Africa
      • 9.5.7.3.1. Market size and forecast, by Therapeutic Class
      • 9.5.7.3.2. Market size and forecast, by Formulation
      • 9.5.7.3.3. Market size and forecast, by Type
      • 9.5.7.3.4. Market size and forecast, by Acne Type
      • 9.5.7.3.5. Market size and forecast, by Distribution Channel
      • 9.5.7.4. Rest of LAMEA
      • 9.5.7.4.1. Market size and forecast, by Therapeutic Class
      • 9.5.7.4.2. Market size and forecast, by Formulation
      • 9.5.7.4.3. Market size and forecast, by Type
      • 9.5.7.4.4. Market size and forecast, by Acne Type
      • 9.5.7.4.5. Market size and forecast, by Distribution Channel

CHAPTER 10: COMPETITIVE LANDSCAPE

  • 10.1. Introduction
  • 10.2. Top winning strategies
  • 10.3. Product mapping of top 10 player
  • 10.4. Competitive dashboard
  • 10.5. Competitive heatmap
  • 10.6. Top player positioning, 2023

CHAPTER 11: COMPANY PROFILES

  • 11.1. AbbVie Inc.
    • 11.1.1. Company overview
    • 11.1.2. Key executives
    • 11.1.3. Company snapshot
    • 11.1.4. Operating business segments
    • 11.1.5. Product portfolio
    • 11.1.6. Business performance
    • 11.1.7. Key strategic moves and developments
  • 11.2. Botanix Pharmaceuticals
    • 11.2.1. Company overview
    • 11.2.2. Key executives
    • 11.2.3. Company snapshot
    • 11.2.4. Operating business segments
    • 11.2.5. Product portfolio
    • 11.2.6. Business performance
    • 11.2.7. Key strategic moves and developments
  • 11.3. Galderma S.A.
    • 11.3.1. Company overview
    • 11.3.2. Key executives
    • 11.3.3. Company snapshot
    • 11.3.4. Operating business segments
    • 11.3.5. Product portfolio
    • 11.3.6. Business performance
    • 11.3.7. Key strategic moves and developments
  • 11.4. Bausch Health Companies Inc
    • 11.4.1. Company overview
    • 11.4.2. Key executives
    • 11.4.3. Company snapshot
    • 11.4.4. Operating business segments
    • 11.4.5. Product portfolio
    • 11.4.6. Business performance
    • 11.4.7. Key strategic moves and developments
  • 11.5. GlaxoSmithKline Plc.
    • 11.5.1. Company overview
    • 11.5.2. Key executives
    • 11.5.3. Company snapshot
    • 11.5.4. Operating business segments
    • 11.5.5. Product portfolio
    • 11.5.6. Business performance
    • 11.5.7. Key strategic moves and developments
  • 11.6. Bayer AG
    • 11.6.1. Company overview
    • 11.6.2. Key executives
    • 11.6.3. Company snapshot
    • 11.6.4. Operating business segments
    • 11.6.5. Product portfolio
    • 11.6.6. Business performance
    • 11.6.7. Key strategic moves and developments
  • 11.7. Kenvue Inc
    • 11.7.1. Company overview
    • 11.7.2. Key executives
    • 11.7.3. Company snapshot
    • 11.7.4. Operating business segments
    • 11.7.5. Product portfolio
    • 11.7.6. Business performance
    • 11.7.7. Key strategic moves and developments
  • 11.8. Pfizer Inc.
    • 11.8.1. Company overview
    • 11.8.2. Key executives
    • 11.8.3. Company snapshot
    • 11.8.4. Operating business segments
    • 11.8.5. Product portfolio
    • 11.8.6. Business performance
    • 11.8.7. Key strategic moves and developments
  • 11.9. Teva Pharmaceutical Industries Ltd.
    • 11.9.1. Company overview
    • 11.9.2. Key executives
    • 11.9.3. Company snapshot
    • 11.9.4. Operating business segments
    • 11.9.5. Product portfolio
    • 11.9.6. Business performance
    • 11.9.7. Key strategic moves and developments
  • 11.10. Mayne Pharma Group Limited.
    • 11.10.1. Company overview
    • 11.10.2. Key executives
    • 11.10.3. Company snapshot
    • 11.10.4. Operating business segments
    • 11.10.5. Product portfolio
    • 11.10.6. Business performance
    • 11.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 02. ACNE MEDICATION MARKET FOR RETINOID, BY REGION, 2023-2035 ($MILLION)
  • TABLE 03. GLOBAL RETINOID ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 04. ACNE MEDICATION MARKET FOR ANTIBIOTIC, BY REGION, 2023-2035 ($MILLION)
  • TABLE 05. GLOBAL ANTIBIOTIC ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 06. ACNE MEDICATION MARKET FOR SALICYLIC ACID, BY REGION, 2023-2035 ($MILLION)
  • TABLE 07. ACNE MEDICATION MARKET FOR BENZOYL PEROXIDE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 08. ACNE MEDICATION MARKET FOR OTHER MEDICATIONS, BY REGION, 2023-2035 ($MILLION)
  • TABLE 09. GLOBAL ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 10. ACNE MEDICATION MARKET FOR TOPICAL MEDICATION, BY REGION, 2023-2035 ($MILLION)
  • TABLE 11. ACNE MEDICATION MARKET FOR ORAL MEDICATION, BY REGION, 2023-2035 ($MILLION)
  • TABLE 12. GLOBAL ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 13. ACNE MEDICATION MARKET FOR PRESCRIPTION MEDICINE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 14. ACNE MEDICATION MARKET FOR OVER-THE-COUNTER MEDICINES, BY REGION, 2023-2035 ($MILLION)
  • TABLE 15. GLOBAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 16. ACNE MEDICATION MARKET FOR NON-INFLAMMATORY ACNE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 17. ACNE MEDICATION MARKET FOR INFLAMMATORY ACNE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 18. GLOBAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 19. ACNE MEDICATION MARKET FOR RETAIL STORE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 20. ACNE MEDICATION MARKET FOR PHARMACY AND DRUG STORE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 21. ACNE MEDICATION MARKET FOR E-COMMERCE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 22. ACNE MEDICATION MARKET, BY REGION, 2023-2035 ($MILLION)
  • TABLE 23. NORTH AMERICA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 24. NORTH AMERICA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 25. NORTH AMERICA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 26. NORTH AMERICA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 27. NORTH AMERICA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 28. NORTH AMERICA ACNE MEDICATION MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 29. U.S. ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 30. U.S. ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 31. U.S. ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 32. U.S. ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 33. U.S. ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 34. CANADA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 35. CANADA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 36. CANADA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 37. CANADA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 38. CANADA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 39. MEXICO ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 40. MEXICO ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 41. MEXICO ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 42. MEXICO ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 43. MEXICO ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 44. EUROPE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 45. EUROPE ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 46. EUROPE ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 47. EUROPE ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 48. EUROPE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 49. EUROPE ACNE MEDICATION MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 50. GERMANY ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 51. GERMANY ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 52. GERMANY ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 53. GERMANY ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 54. GERMANY ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 55. FRANCE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 56. FRANCE ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 57. FRANCE ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 58. FRANCE ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 59. FRANCE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 60. UK ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 61. UK ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 62. UK ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 63. UK ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 64. UK ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 65. ITALY ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 66. ITALY ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 67. ITALY ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 68. ITALY ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 69. ITALY ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 70. SPAIN ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 71. SPAIN ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 72. SPAIN ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 73. SPAIN ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 74. SPAIN ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 75. REST OF EUROPE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 76. REST OF EUROPE ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 77. REST OF EUROPE ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 78. REST OF EUROPE ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 79. REST OF EUROPE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 80. ASIA-PACIFIC ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 81. ASIA-PACIFIC ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 82. ASIA-PACIFIC ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 83. ASIA-PACIFIC ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 84. ASIA-PACIFIC ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 85. ASIA-PACIFIC ACNE MEDICATION MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 86. JAPAN ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 87. JAPAN ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 88. JAPAN ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 89. JAPAN ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 90. JAPAN ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 91. CHINA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 92. CHINA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 93. CHINA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 94. CHINA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 95. CHINA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 96. AUSTRALIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 97. AUSTRALIA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 98. AUSTRALIA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 99. AUSTRALIA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 100. AUSTRALIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 101. INDIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 102. INDIA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 103. INDIA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 104. INDIA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 105. INDIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 106. SOUTH KOREA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 107. SOUTH KOREA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 108. SOUTH KOREA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 109. SOUTH KOREA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 110. SOUTH KOREA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 111. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 112. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 113. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 114. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 115. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 116. LAMEA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 117. LAMEA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 118. LAMEA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 119. LAMEA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 120. LAMEA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 121. LAMEA ACNE MEDICATION MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 122. BRAZIL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 123. BRAZIL ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 124. BRAZIL ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 125. BRAZIL ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 126. BRAZIL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 127. SAUDI ARABIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 128. SAUDI ARABIA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 129. SAUDI ARABIA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 130. SAUDI ARABIA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 131. SAUDI ARABIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 132. SOUTH AFRICA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 133. SOUTH AFRICA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 134. SOUTH AFRICA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 135. SOUTH AFRICA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 136. SOUTH AFRICA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 137. REST OF LAMEA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 138. REST OF LAMEA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 139. REST OF LAMEA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 140. REST OF LAMEA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 141. REST OF LAMEA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 142. ABBVIE INC.: KEY EXECUTIVES
  • TABLE 143. ABBVIE INC.: COMPANY SNAPSHOT
  • TABLE 144. ABBVIE INC.: PRODUCT SEGMENTS
  • TABLE 145. ABBVIE INC.: SERVICE SEGMENTS
  • TABLE 146. ABBVIE INC.: PRODUCT PORTFOLIO
  • TABLE 147. ABBVIE INC.: KEY STRATEGIES
  • TABLE 148. BOTANIX PHARMACEUTICALS: KEY EXECUTIVES
  • TABLE 149. BOTANIX PHARMACEUTICALS: COMPANY SNAPSHOT
  • TABLE 150. BOTANIX PHARMACEUTICALS: PRODUCT SEGMENTS
  • TABLE 151. BOTANIX PHARMACEUTICALS: SERVICE SEGMENTS
  • TABLE 152. BOTANIX PHARMACEUTICALS: PRODUCT PORTFOLIO
  • TABLE 153. BOTANIX PHARMACEUTICALS: KEY STRATEGIES
  • TABLE 154. GALDERMA S.A.: KEY EXECUTIVES
  • TABLE 155. GALDERMA S.A.: COMPANY SNAPSHOT
  • TABLE 156. GALDERMA S.A.: PRODUCT SEGMENTS
  • TABLE 157. GALDERMA S.A.: SERVICE SEGMENTS
  • TABLE 158. GALDERMA S.A.: PRODUCT PORTFOLIO
  • TABLE 159. GALDERMA S.A.: KEY STRATEGIES
  • TABLE 160. BAUSCH HEALTH COMPANIES INC: KEY EXECUTIVES
  • TABLE 161. BAUSCH HEALTH COMPANIES INC: COMPANY SNAPSHOT
  • TABLE 162. BAUSCH HEALTH COMPANIES INC: PRODUCT SEGMENTS
  • TABLE 163. BAUSCH HEALTH COMPANIES INC: SERVICE SEGMENTS
  • TABLE 164. BAUSCH HEALTH COMPANIES INC: PRODUCT PORTFOLIO
  • TABLE 165. BAUSCH HEALTH COMPANIES INC: KEY STRATEGIES
  • TABLE 166. GLAXOSMITHKLINE PLC.: KEY EXECUTIVES
  • TABLE 167. GLAXOSMITHKLINE PLC.: COMPANY SNAPSHOT
  • TABLE 168. GLAXOSMITHKLINE PLC.: PRODUCT SEGMENTS
  • TABLE 169. GLAXOSMITHKLINE PLC.: SERVICE SEGMENTS
  • TABLE 170. GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
  • TABLE 171. GLAXOSMITHKLINE PLC.: KEY STRATEGIES
  • TABLE 172. BAYER AG: KEY EXECUTIVES
  • TABLE 173. BAYER AG: COMPANY SNAPSHOT
  • TABLE 174. BAYER AG: PRODUCT SEGMENTS
  • TABLE 175. BAYER AG: SERVICE SEGMENTS
  • TABLE 176. BAYER AG: PRODUCT PORTFOLIO
  • TABLE 177. BAYER AG: KEY STRATEGIES
  • TABLE 178. KENVUE INC: KEY EXECUTIVES
  • TABLE 179. KENVUE INC: COMPANY SNAPSHOT
  • TABLE 180. KENVUE INC: PRODUCT SEGMENTS
  • TABLE 181. KENVUE INC: SERVICE SEGMENTS
  • TABLE 182. KENVUE INC: PRODUCT PORTFOLIO
  • TABLE 183. KENVUE INC: KEY STRATEGIES
  • TABLE 184. PFIZER INC.: KEY EXECUTIVES
  • TABLE 185. PFIZER INC.: COMPANY SNAPSHOT
  • TABLE 186. PFIZER INC.: PRODUCT SEGMENTS
  • TABLE 187. PFIZER INC.: SERVICE SEGMENTS
  • TABLE 188. PFIZER INC.: PRODUCT PORTFOLIO
  • TABLE 189. PFIZER INC.: KEY STRATEGIES
  • TABLE 190. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY EXECUTIVES
  • TABLE 191. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
  • TABLE 192. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT SEGMENTS
  • TABLE 193. TEVA PHARMACEUTICAL INDUSTRIES LTD.: SERVICE SEGMENTS
  • TABLE 194. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
  • TABLE 195. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATEGIES
  • TABLE 196. MAYNE PHARMA GROUP LIMITED.: KEY EXECUTIVES
  • TABLE 197. MAYNE PHARMA GROUP LIMITED.: COMPANY SNAPSHOT
  • TABLE 198. MAYNE PHARMA GROUP LIMITED.: PRODUCT SEGMENTS
  • TABLE 199. MAYNE PHARMA GROUP LIMITED.: SERVICE SEGMENTS
  • TABLE 200. MAYNE PHARMA GROUP LIMITED.: PRODUCT PORTFOLIO
  • TABLE 201. MAYNE PHARMA GROUP LIMITED.: KEY STRATEGIES

LIST OF FIGURES

  • FIGURE 01. ACNE MEDICATION MARKET, 2023-2035
  • FIGURE 02. SEGMENTATION OF ACNE MEDICATION MARKET,2023-2035
  • FIGURE 03. TOP IMPACTING FACTORS IN ACNE MEDICATION MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN ACNE MEDICATION MARKET (2024-2035)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL ACNE MEDICATION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023 AND 2035(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR RETINOID, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR ANTIBIOTIC, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR SALICYLIC ACID, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR BENZOYL PEROXIDE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR OTHER MEDICATIONS, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 17. ACNE MEDICATION MARKET, BY FORMULATION, 2023 AND 2035(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR TOPICAL MEDICATION, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR ORAL MEDICATION, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 20. ACNE MEDICATION MARKET, BY TYPE, 2023 AND 2035(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR PRESCRIPTION MEDICINE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR OVER-THE-COUNTER MEDICINES, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 23. ACNE MEDICATION MARKET, BY ACNE TYPE, 2023 AND 2035(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR NON-INFLAMMATORY ACNE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR INFLAMMATORY ACNE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 26. ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023 AND 2035(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR RETAIL STORE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 28. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR PHARMACY AND DRUG STORE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 29. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR E-COMMERCE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 30. ACNE MEDICATION MARKET BY REGION, 2023 AND 2035(%)
  • FIGURE 31. U.S. ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 32. CANADA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 33. MEXICO ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 34. GERMANY ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 35. FRANCE ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 36. UK ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 37. ITALY ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 38. SPAIN ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 39. REST OF EUROPE ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 40. JAPAN ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 41. CHINA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 42. AUSTRALIA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 43. INDIA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 44. SOUTH KOREA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 45. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 46. BRAZIL ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 47. SAUDI ARABIA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 48. SOUTH AFRICA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 49. REST OF LAMEA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 50. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 54. COMPETITIVE DASHBOARD
  • FIGURE 55. COMPETITIVE HEATMAP: ACNE MEDICATION MARKET
  • FIGURE 56. TOP PLAYER POSITIONING, 2023